Do not approve “the sample.” Approve an identified version and its transfer rules.
Use this gummy sample approval and commercial scale-up checklist to define what must stay fixed, what may move within a range, which differences require approval and what evidence closes the first production batch.
A prototype, a manufacturing instruction and a production record are different evidence
A prototype shows the attributes of an identified sample. A master manufacturing record controls how a defined formulation and batch size are manufactured. A batch production record documents what happened for an identified commercial batch. The transfer file should connect them without pretending that one document replaces the others.
Five control points from concept to first commercial batch
Project basis
Market, serving, label direction, package and decision owners.
Identified sample
Sample ID, formula version, date, conditions and observed attributes.
Transfer decision
Fixed, ranged, target and reference-only characteristics plus approved differences.
Controlled production
Applicable master record, batch record, specifications and packaging revision.
First-batch closure
Results, deviations, quality disposition, buyer review and claim boundary.
Classify every approved characteristic
“Match the sample” is not a complete instruction. For each characteristic, choose a decision class and state who can approve a change.
Fixed
An identifier or requirement that must not change without a controlled revision—for example, declared ingredient form, serving or approved label revision.
Acceptance range
A measurable interval or limit with an identified unit and method. Results inside the range are conforming under the defined conditions.
Target
A development objective that guides optimization but is not yet the final pass/fail criterion. Do not report it as a released result.
Reference-only
A sensory or visual comparator that informs review but cannot by itself replace controlled quantitative or qualitative criteria.
The sample approval packet: 10 fields to close before scale-up
1. Sample identity
- Sample code and creation date
- Formula/revision cross-reference
- Quantity and package used for evaluation
- Storage and evaluation conditions
2. Project and market scope
- Product/SKU and intended market
- Serving, piece count and label direction
- Customer, manufacturer and approver entities
- Intended commercial package
3. Formula linkage
- Ingredient forms and declared amounts
- Component or grade restrictions where applicable
- Approved substitutions or open choices
- Confidential owner of the controlled formula
4. Physical and sensory review
- Piece weight, dimensions, shape and coating
- Appearance, color, odor, flavor and texture
- Method or controlled reference for each decision
- Observed variation within the sample set
5. Analytical and quality criteria
- Identity, strength, composition and applicable purity criteria
- Defined contaminant and microbiological criteria
- Methods, units, sample basis and laboratory responsibility
- Which results are development-only versus release criteria
6. Packaging transfer
- Container, closure, liner, seal and count
- Label/artwork revision and lot coding
- Difference between sample pack and commercial pack
- Stability evidence linked to the actual package
7. Known scale differences
- Sample and intended commercial batch sizes
- Equipment or process-stage differences
- Expected effect on product attributes
- Planned verification or bridging evidence
8. Open deviations
- Every difference from the target or previous version
- Impact assessment and disposition owner
- Correction, acceptance or resampling decision
- Due date before commercial authorization
9. Change notification
- Formula, supplier, grade and process triggers
- Batch-size, method, package and label triggers
- Required buyer notice or reapproval
- Emergency-change and retrospective-review path
10. Sign-off and rights
- Technical, quality, packaging and commercial approvers
- Approval date and effective revision
- Permitted internal and public use of evidence
- Statement that approval does not guarantee an unreviewed future batch
Transfer matrix: connect the approved sample to production evidence
| Transfer item | Sample-stage evidence | Commercial-stage evidence | Buyer decision |
|---|---|---|---|
| Formula/version | Identified prototype formula reference | Applicable master manufacturing record and batch-size revision | Same, approved difference or unresolved |
| Components | Sample ingredient forms and sources recorded | Component IDs, quantities and receiving/release records | Specified restrictions and substitutions satisfied |
| Physical attributes | Measured or controlled reference results | In-process monitoring and finished-batch results | Within approved criteria or disposition needed |
| Analytical attributes | Development result tied to sample/method | Applicable commercial-batch result and specification | Do not transfer a sample result to an untested batch |
| Package/label | Prototype pack or artwork reference | Commercial components, label revision and examination | Differences approved and stability scope reviewed |
| Deviation/change | Open issue and development decision | Material review, corrective action or approved revision | Closed, conditionally accepted or rejected |
| Release | Sample approval for the stated purpose | Quality-control review and release/rejection of the batch | Commercial acceptance based on the identified batch file |
Why the master record and batch record matter during scale-up
Under 21 CFR 111.205, a written master manufacturing record is prepared and followed for each unique dietary-supplement formulation and each batch size to support finished-batch uniformity. It identifies specifications at the process points where control is needed and establishes controls and procedures intended to ensure that each batch meets those specifications.
21 CFR 111.210 lists master-record elements including the product and dietary-ingredient amounts for each batch size, components and quantities, theoretical yields, packaging and representative label, written instructions, sampling and test references, verification actions, precautions and corrective-action plans. A customer-approved prototype does not contain all of that information by itself.
For each manufactured batch, 21 CFR 111.255 requires a batch production record with complete production and control information that accurately follows the appropriate master record. Section 111.260 connects the batch to equipment, component identifiers and quantities, yields, monitoring, test results, finished-product and packaging/labeling specifications, performed steps, deviations and the quality-control release or rejection decision.
First commercial batch review: do not stop at “COA attached”
- Match identifiers. Confirm the project, formula, specification, approved sample, master-record revision, batch, package and label are linked.
- Reconcile approved differences. Check every planned and unplanned difference from the prototype and its disposition.
- Review the defined results. Compare results with the approved criteria, methods, units and sampling basis—not with a marketing target. Use the laboratory report checklist for sample identity, method suitability and result limitations.
- Review execution evidence. Verify the applicable batch-record, monitoring, packaging/labeling and quality-review evidence available under the agreed document map.
- Separate commercial acceptance from regulatory release. Record the manufacturer's quality disposition and the buyer's contractual acceptance as distinct decisions.
- Limit public wording. Publish only statements supported by the identified evidence, exact scope and authorized disclosure rights.
Change triggers that should reopen the transfer review
- Ingredient form, formula amount, declared serving or ingredient-list change.
- Component supplier, grade or material specification change that may affect the product.
- Batch-size, equipment, site, manufacturing stage or controlled-process change with potential product impact.
- Test method, laboratory, unit, sampling or acceptance-criterion change.
- Gummy weight, shape, coating, color, flavor, texture or other approved physical-attribute change.
- Container, closure, count, label, storage assumption or target-market change. Use the packaging change-control checklist to compare the old and new configurations.
- Deviation, complaint, stability signal or result that calls the approved transfer basis into question. Use the complaint and OOS investigation checklist to control the response and disposition.
Copy-ready sample-to-commercial transfer request
Send this after selecting a prototype. Leave unknown fields open and ask the responsible party to identify the controlled source rather than guessing.
Connect the transfer file to the rest of supplier qualification
Start with the manufacturing feasibility checklist, define criteria using the product specification checklist, reconcile the effective label with the label and artwork approval checklist, use the packaging change-control checklist for any commercial package substitution, and use the COA and batch-records guide to identify the evidence expected at commercial release. Record document status and disclosure rights in the project evidence register.
For Sucotond projects, the Brooklyn office can organize non-confidential transfer questions for factory review. The factory remains responsible for its controlled manufacturing and quality records; the buyer remains responsible for its approvals and market requirements. A preliminary discussion or sample approval is not a promise about an unreviewed commercial batch.
Shelf-life evidence checklist
Check whether the stability evidence belongs to the transferred formula, package, conditions and proposed date.
Review stability →24-point qualification checklist
Review the legal entity, facility, records, testing, packaging and commercial responsibilities.
Open checklist →Frequently asked questions
Does approving a gummy sample guarantee that a commercial batch will be identical?
No. A sample is evidence about the identified prototype under its documented conditions. Commercial transfer should define which attributes are fixed, ranged, targeted or reference-only, identify approved differences, and verify the commercial batch against the applicable specification and records.
Is an approved sample the same as a master manufacturing record?
No. An approved sample may help communicate product expectations. A master manufacturing record is a controlled manufacturing record for each unique formulation and batch size and includes the components, quantities, packaging, instructions, specifications, sampling and testing references, controls and corrective-action plans required by the applicable rule.
Should a brand receive every proprietary process parameter from its gummy manufacturer?
Not necessarily. The parties should identify what information is controlled by the manufacturer, what the buyer may review, and which product, package, testing, change-notification and release outcomes must be documented. Confidential process details and buyer-verifiable acceptance evidence are different issues.
Which changes should trigger a gummy sample or transfer review?
Potential triggers include a formula or ingredient-form change, component supplier or grade change, batch-size or process change, test-method change, package or label change, market change, serving change, or a material difference from the approved physical and sensory reference.
What should a buyer review for the first commercial gummy batch?
Match the project, formula, specification, sample, commercial batch, package and label identifiers; review approved transfer differences, applicable test results, batch-record evidence and quality disposition; and document any unresolved deviation before accepting or publishing claims about the batch.
Official references and scope
This page combines U.S. dietary-supplement CGMP record concepts with a voluntary buyer transfer workflow. It is not a master manufacturing record, batch production record, quality agreement, legal opinion or regulatory approval. “Sample approval” and “commercial transfer” fields should be adapted by qualified quality, regulatory and manufacturing personnel.
- 21 CFR 111.205 — Master manufacturing record requirement
- 21 CFR 111.210 — Master manufacturing record contents
- 21 CFR 111.255 — Batch production record requirement
- 21 CFR 111.260 — Batch production record contents
- FDA — Dietary Supplement CGMP Small Entity Compliance Guide
- FDA Food Compliance Programs — Program 7321.008: Dietary Supplements
Have an approved prototype but no commercial transfer map?
Share the non-confidential sample, specification, package, target market and open differences. Our U.S. team will organize the questions for factory review.
Request a Project Review